Venture Investment & Partnering (VIP) Forum: MedImmune Ventures

The Washington Biotechnology & Biomedical Association is hosting a Venture Investment and Partnering (VIP) forum with MedImmune Ventures on May 23. For more information on how to register, click here.

Interested in Seattle Events?

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
IBM Watson Health Data in Action – Epidemiology Studies
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
IBM Watson

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy Seattle

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Menlo’s Itching Drug Racks Up Two More Trial Failures, Program Ends

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

GSK, Vir Team Up in COVID-19 Pact Aiming to Reach the Clinic in Months

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Xconomy Releases Coronavirus Special Report on Containing the Pandemic Through Innovation & Investment

Viracta Adds Nordic Nanovector’s Lisa Rojkjaer as Chief Medical Officer

Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus

Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More

Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More

Xcelerating Life Sciences Boston (interactive online event)

Xcelerating Life Sciences Philadelphia (interactive online event)

Xcelerating Life Sciences San Francisco (interactive online event)

Venture Investment & Partnering (VIP) Forum: MedImmune Ventures

Share

Interested in Seattle Events?

Underwriters and Partners

IBM Watson Health Data in Action – Epidemiology Studies

Potency Assay Development for Cell and Gene Therapy Products

How to Approach Life Sciences Fundraising

Xconomy on Demand

We offer a number of ways to subscribe for free!